HFE gene mutation, C282Y causing hereditary hemochromatosis in caucasian is extremely rare in Korean population

Journal of Korean Medical Science

Volumn 15, Issue 2, 2000, Pages 179-182

  Lee, Ji Yon ^a   Yoo, Kyung Hwa ^a   Hahn, Si Houn ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Hemochromatosis, Genes; Korea; Mutation; Point Mutation

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; PRIMER DNA;

ALLELE; ARTICLE; ASIAN; CAUCASIAN; ETHNOLOGY; GENETIC SCREENING; GENETICS; GENOTYPE; HEMOCHROMATOSIS; HUMAN; KOREA; POINT MUTATION; PREVALENCE;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; DNA PRIMERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; KOREA; POINT MUTATION; PREVALENCE;

EID: 0034170208     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2000.15.2.179     Document Type: Article

References (21)

1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Minter GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 1996; 13: 399-408.
2. Jazwinska EC, Cullen LM, Busfield F, Pyper WR, Webb SI, Powell LW, Morris CP, Walsh TP. Haemochromatosis and HLA-H. Nature Genet 1996; 14: 249-51.
3. Jouanolle AM, Gandon G, Jezeqquel P, Blayau M, Campion ML, Yaouanq J, Mosser J, Fergelot P, Chauvel B, Bouric P, Cam G, Andrieux N, Gicquel I, Le Gahl JY, David V. Haemochromatosis and HLA-H. Nature Genet 1996; 14: 251-2.
4. Takeuchi T, Soejima H, Faed JM, Yun K. Efficient large-scale screening for the hemochromatosis susceptibility gene mutation. Blood 1997; 90: 2848-9.
5. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-8.
6. Simon M. Disorders of iron metabolism and related disorders. In: Emery AE, Rimoin DL, eds. Principle and practice of medical genetics. 2nd ed. Edinburgh: Churchill Livingstone, 1990; 1783-96.
7. Beutler E, Gelbart T, West C, Lee P, Adams M, Blackstone R, Pockros P, Kosty M, Venditti CP, Phatak PD, Seese NK, Chorney KA, Ten Elshof AE, Gerhard GS, Chorney M. Mutation analysis in hereditary hemochromatosis. Blood Cell Mol Dis 1996; 22: 187-94.
8. Jouanolle AM, Fergelot P, Gandon G, Yaouanq J, Le Gall JY, David V. A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations. Hum Genet 1997; 100: 544-7.
9. Cogswell ME, Burke W, McDonnell SM, Franks AL. Screening for hemochromatosis. A public health perspective. Am J Prev Med 1999; 16: 134-40.
10. Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, Walmsley TA, Chapman BA. The significance of haemochromatosis gene mutations in the general population: implications for screening. Gut 1998; 43: 830-6.
11. Burke W, Thomson E, Khoury MJ, McDonnell SM, Press N, Adams PC, Barton JC, Beutler E, Brittenham G, Buchanan A, Clayton EW, Cogswell ME, Meslin EM, Motulsky AG, Powell LW, Sigal E, Wilfond BS, Collins FS. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA 1998; 280: 172-8.
12. Beckman LE, Saha N, Spitsyn V, Van Landeghem G, Beckman L. Ethnic differences in the HFE codon 282 (Cys/Tyr) polymorphism. Hum Hered 1997; 47: 263-7.
13. Datz C, Lalloz MR, Vogel W, Graziadei I, Hackl F, Vautier G, Layton DM, Maier-Dobersberger T, Ferenci P, Penner E, Sandhofer F, Bomford A, Paulweber B. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis. J Hepatol 1997; 27: 773-9.
14. Jezequel P, Bargain M, Lellouche F, Geffroy F, Dorval I. Allele frequencies of hereditary hemochromatosis gene mutations in a local population of west Brittany. Hum Genet 1998; 102: 332-3.
15. Cardoso EM, Stal P, Hagen K, Cabeda JM, Esin S, de Sousa M, Hultcrantz R. HFE mutations in patients with hereditary haemochromatosis in Sweden. J Intern Med 1998; 243: 203-8.
16. Sanchez M, Bruguera M, Bosch J, Rodes J, Ballesta F, Oliva R. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol 1998; 29: 725-8.
17. Merryweather-Clarke AT, Simonsen H, Shearman JD, Pointon JJ, Norgaard-Pedersen B, Robson KJ. A retrospective anonymous pilot study in screening newborns for HFE mutations in Scandinavian populations. Hum Mutat 1999; 13: 154-9.
18. Chang JG, Lui TC, Lin SF. Rapid diagnosis of the HLA-H gene Cys282Tyr mutation in hemochromatosis by polymerase chain reaction-a very rare mutation in the Chinese population. Blood 1997; 89: 3492-3.
19. Sohda T, Yanai J, Soejima H, Tamura K. Frequencies in the Japanese population of HFE gene mutations. Biochem Genet 1999; 37: 63-822.
20. Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Intern Med 1999; 130: 953-62.
21. Smith BC, Gorve J, Guzail MA, Day CP, Daly AK, Burt AD, Bassendine MF. Heterozygosity for hereditary hemochromatosis is associated with more flbrosis in chronic hepatitis C. Hepatology 1998; 27: 1695-9.